The Downregulation of ITGAX Exacerbates Amyloid-β Plaque Deposition in Alzheimer’s Disease by Increasing Polarization of M1 Microglia
Journal of Alzheimer's Disease · 2024
DOI: 10.3233/jad-240118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Yufei Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Down-Regulation, Mice, Transgenic, Microglia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) is the most common sort of neurodegenerative dementia, characterized by its challenging, diverse, and progressive nature. Despite significant progress in neuroscience, the current treatment strategies remain suboptimal.
Objective
Identifying a more accurate molecular target for the involvement of microglia in the pathogenic process of AD and exploring potential mechanisms via which it could influence disease.
Methods
We utilized single-cell RNA sequencing (scRNA-seq) analysis in conjunction with APP/PS1 mouse models to find out the molecular mechanism of AD. With the goal of investigating the cellular heterogeneity of AD, we downloaded the scRNA-seq data from the Gene Expression Omnibus (GEO) database and identified differentially expressed genes (DEGs). Additionally, we evaluated learning and memory capacity using the behavioral experiment. We also examined the expression of proteins associated with memory using western blotting. Immunofluorescence was employed to investigate alterations in amyloid plaques and microglia.
Results
Our findings revealed an upregulation of ITGAX expression in APP/PS1 transgenic mice, which coincided with a downregulation of synaptic plasticity-related proteins, an increase in amyloid-β (Aβ) plaques, and an elevation in the number of M1 microglia. Interestingly, deletion of ITGAX resulted in increased Aβ plaque deposition, a rise in the M1 microglial phenotype, and decreased production of synaptic plasticity-related proteins, all of which contributed to a decline in learning and memory.
Conclusions
This research suggested that ITGAX may have a beneficial impact on the APP/PS1 mice model, as its decreased expression could exacerbate the impairment of synaptic plasticity and worsen cognitive dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- Department of Anesthesiology, Hebei Provincial Chest Hospital, Shijiazhuang, Hebei, China.
- Department of Pathophysiology, Hebei Medical University, Shijiazhuang, Hebei, China.
Zitieren
APA
Hu, Y., Wang, X., Zhao, Z., Liu, M., Ren, X., Xian, X., Liu, C., & Wang, Q. (2024). The Downregulation of ITGAX Exacerbates Amyloid-β Plaque Deposition in Alzheimer’s Disease by Increasing Polarization of M1 Microglia. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-240118
Vancouver
Hu Y, Wang X, Zhao Z, Liu M, Ren X, Xian X, et al. The Downregulation of ITGAX Exacerbates Amyloid-β Plaque Deposition in Alzheimer’s Disease by Increasing Polarization of M1 Microglia. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-240118
BibTeX
@article{Hu2024,
author = {Hu, Yufei and Wang, Xupeng and Zhao, Zijun and Liu, Menglin and Ren, Xiaoqin and Xian, Xiaohui and Liu, Chunxiao and Wang, Qiujun},
title = {The Downregulation of ITGAX Exacerbates Amyloid-β Plaque Deposition in Alzheimer’s Disease by Increasing Polarization of M1 Microglia},
journal = {Journal of Alzheimer's Disease},
year = {2024},
doi = {10.3233/jad-240118}
}
EUVIMED